Browse the full directors' dealings record of MassRoots, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Others sector, MassRoots, Inc. has logged 2 public disclosures. The latest transaction was filed on 20 October 2021 — J. Among the most active insiders: Meeks Danny. All data is openly available.
2 of 2 declarations
MassRoots, Inc. is a U.S.-listed small-cap issuer that investors should view as a highly speculative microcap rather than a mature operating company. Historically, the business has been associated with the cannabis technology space and with a series of strategic resets over time; for an international investor, the key point is to verify the latest SEC filings before assuming any stable operating model. The company was founded in April 2013 as a technology platform for the cannabis industry. In its SEC history, MassRoots described itself as a cannabis social network designed to help users research strains and product information, locate dispensaries and products, and follow cannabis-related news. Its operating footprint is in the United States; older filings referenced Los Angeles, California, although the company’s filings over the years indicate a business that has undergone multiple structural changes. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1589149/000172186818000117/f2msrt021318s1.htm?utm_source=openai)) From a business-model perspective, MassRoots has historically focused on digital tools and content for the cannabis ecosystem: discovery, community engagement, product information, and compliance-related information services. That positioning made it more of a niche technology company than a plant-touching cannabis producer or distributor. Its competitive position has depended on user engagement, partner relationships, and the ability to monetize attention in a fragmented and heavily regulated market. However, the company has also experienced repeated capital-structure changes and strategic shifts, so investors should avoid assuming that its current revenue base, product set, or end-market exposure matches the company’s legacy positioning without checking the latest SEC disclosure. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1589149/000072174817000390/msrt8k060717ex99_1.htm?utm_source=openai)) Historically, notable milestones included the 2013 founding, growth initiatives in medical cannabis, and transactions intended to broaden the platform’s compliance and information capabilities. One frequently cited event in the SEC archive is the announced acquisition of CannaRegs in 2017, which reinforced the company’s ambition to add regulatory and market-compliance functionality. For French-speaking investors, the important framing is that MassRoots is not a large-cap benchmark name on the NYSE or NASDAQ; it is a United States microcap with limited visibility, higher execution risk, and a profile that can change materially with financing, dilution, and regulatory developments. Recent SEC filings should be checked to confirm whether the company still centers on cannabis-related technology or has moved into another business scope. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1589149/000072174817000572/msrt8k082417ex99_1.htm?utm_source=openai))